Startup
Description
AIRA Health is building a new era in clinical development. Every failed or delayed study delays a cure, and most delays trace back to decisions made during trial design and protocol development. That's where AIRA focuses.
Our platform, Colligo, is a collaborative AI workspace for biopharma teams. Built-in AI thought partners - with expert-level clinical, regulatory, biostatistical, and medical writing capabilities - work alongside the team, continuously tracking the evolving study context and developing it together with them. Unlike rigid template-based tools, AIRA adapts to the way each study unfolds.
Measurable impact for our clients: 40% faster protocol turnaround, $150K to $1.2M+ saved per trial in planning and expert costs, and prevention of avoidable amendments (~$450K each). AIRA Health is headquartered in Budapest and Boston, and was incubated at the Harvard Innovation Labs.
